Table 1.
Mechanism and gene | Function | p53 Dependent† | p53 Independent† | Reference |
Mitotic and stress signaling | ||||
Raf1 | Mitogenic/stress signaling | + | (26) | |
MAP2K6/p38 | Mitogenic/stress signaling | + | (27) | |
Aurora kinase A | Mitogenic signaling | + | (28) | |
PTEN | Oncogenic stress signaling | + | (29) | |
SKP2 | Mitogenic/stress signaling | (30) | ||
Major tumor suppressors | ||||
p53 | Transcription factor | + | (31) | |
p63 | Transcription factor | + | (32) | |
p73 | Transcription factor | + | (32) | |
Rb | Transcription regulator | + | (33) | |
CDKIs | ||||
p21Waf1/Cip1 | Kinase inhibitor | + | (34) | |
p16Ink4a | Kinase inhibitor | + | (35) | |
p57Kip2 | Kinase inhibitor | (36) | ||
p15Ink4b | Kinase inhibitor | (37) | ||
Mitochondrial integrity and function | ||||
OPA1 | Mitochondrial membrane structure | + | (38) | |
Proinflammatory signaling | ||||
IL-6/CXCR2 | Cytokine/receptor | + | (39) | |
IGFBP-rP1 | Cytokine/IGF signaling, modulators | (40) | ||
IGFBP7 | + | + | (41) |
CXCR2 = chemokine (C-X-C motif) receptor 2; IL-6 = interleukin 6; IGFBP-rP1= insulinlike growth factor–binding protein-related protein 1; IGFBP7 = insulinlike growth factor–binding protein 7; MAP2K6 = mitogen-activated protein kinase kinase 6; OPA1= optic atrophy 1; p38 = mitogen-activated protein kinase 14; p21Waf1/Cip1 = CDKN1A/cyclin-dependent kinase inhibitor 1A; p16Ink4a = CDKN2A/cyclin-dependent kinase inhibitor 2a; p57Kip2 = cyclin-dependent kinase inhibitor 1C; p15Ink4b = cyclin-dependent kinase inhibitor 2B; PTEN = phosphatase and tensin homolog; Raf1 = raf-1 murine leukemia viral oncogene homolog 1; Rb = retinoblastoma protein; Skp2 = S-phase kinase-associated protein 2.
Senescence-inducing activity shown to be dependent or independent of intact p53 function, denoted by (+). Blank means undetermined.